Learn more about our Advocacy work.
AdvaMed®, the world’s largest trade organization representing medical technology companies, released the following statement from President and CEO Scott Whitaker on the unveiling by U.S. Reps. Diana DeGette (D-Colo.) and…
President and CEO of AdvaMed® Scott Whitaker sent a letter to President Biden on behalf of the medical technology industry asking “the Administration to make the transport of medical supplies…
Dr. Jeff Shuren, the head of FDA’s medical device division, told a medtech audience on a podcast released this week that the agency should “re-envision” the medical device regulatory framework.
The long-term implications of state right-to-repair laws could have devastating consequences for health care providers and their patients.
AdvaMed®, the world’s largest trade organization representing medical technology manufacturers, released the following statement from President and CEO Scott Whitaker upon Chiquita Brooks-LaSure’s confirmation by the Senate as Administrator of…
AdvaMed®, the world’s largest trade organization representing medical technology companies, wrote a letter to U.S. Department of Commerce Secretary Gina Raimondo “to strongly encourage the implementation of policies that ensure…
A large group of Democratic lawmakers is requesting that the Biden administration enact a finalized federal rule that would give seniors on Medicare access to life-saving medical treatments.
Thought leaders across the country are urging the Administration to enact the Medicare Coverage of Innovative Technology (MCIT) rule that was set to go into effect March 15 before it…
A growing number of patient groups are expressing their support to the Centers for Medicare & Medicaid Services (CMS) of the Medicare Coverage of Innovative Technology (MCIT) rule.
Creating a clear and consistent pathway to coverage for new and innovative medical technologies will ensure Medicare patients’ access to life-saving and life-enhancing care.